worldwiki
医疗 · Plastic Surgery

Breast Fat Grafting

别名: 自体脂肪移植丰胸, 无假体隆胸, 脂肪填充丰胸, 脂肪移植隆胸, 自体脂肪丰胸, 自体脂肪隆胸, fat transfer breast augmentation, 自体脂肪移植

发布 2026年9月14日更新 2026年9月20日
来自本站服务器日志的请求记录,爬虫身份通过反向 DNS 或 IP 段核验。Google22OpenAI3Anthropic1Yandex1Apple1首次采集 2026年9月15日最近请求Google2026年9月20日Google2026年9月20日Google2026年9月20日Google2026年9月20日OpenAI2026年9月20日OpenAI2026年9月20日OpenAI2026年9月20日Apple2026年9月20日Google2026年9月19日Google2026年9月19日Google2026年9月19日Google2026年9月19日
请求更正
语言English尚未翻译为该语言,此处显示英文原文。
定义

Breast fat grafting (fat transfer breast augmentation) uses the patient's own liposuctioned fat to modestly enlarge or reshape the breast without an implant.

快速回答

What is breast fat grafting?

Breast fat grafting, or fat transfer breast augmentation, enlarges or reshapes the breast using fat taken from the patient's own body by liposuction. The fat is processed and injected into the breast in small amounts. It gives a modest, natural increase without an implant, but part of the graft is resorbed, so more than one session may be needed.

已验证 2026年9月15日

关键事实

属性来源
DefinitionFat is taken by liposuction from other parts of the body and injected to enlarge the breasts[2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons
Typical donor sitesUsually the abdomen or flanks, though fat can be taken from almost anywhere (surgeon quoted by ASPS)截至 2024年11月18日[3]organizationFat transfer for breast augmentation: The ins and outs of this implant alternativeAmerican Society of Plastic Surgeons
Typical size increaseSurgeon quoted by ASPS: ideal candidate wants half a cup to one cup; a larger increase may take two to three procedures cup size截至 2024年11月18日[3]organizationFat transfer for breast augmentation: The ins and outs of this implant alternativeAmerican Society of Plastic Surgeons
Listed risksCysts, infection, microcalcification, death of fat cells (necrosis), and some transferred fat leaving the breast area[2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons
Pre-expansion optionSurgeons may recommend an external tissue expansion system in the weeks before surgery[2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons
Pooled volume retention54% (95% CI 48.5–59.5%) across 25 studies, follow-up 3–36 months percent截至 2024年2月1日[4]journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract recordJournal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC)
Retention by fat preparation methodCentrifugation 51.5% vs sedimentation 38.7% pooled retention percent截至 2024年2月1日[4]journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract recordJournal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC)
Oncologic safety evidenceMeta-analysis of 15 studies (8,541 participants): no difference in overall survival, disease-free survival or local recurrence between patients who had fat grafting after breast cancer surgery and controls截至 2022年4月1日[5]journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract recordBMC Cancer (via Europe PMC)
1987 professional positionASPRS (predecessor of ASPS) condemned autologous fat injection for breast augmentation over concerns about cancer detection[6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central
2009 ASPS Fat Graft Task ForceConcluded that the literature then available showed no association between fat grafting and higher rates of malignancy[6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central
US regulatory statusFollowing FDA guidance issued in November 2017, autologous fat grafts do not require premarket approval; stromal vascular fraction products receive closer review截至 2017年11月1日[6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central
Relevant FDA guidanceSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception截至 2017年11月1日[7]governmentSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the ExceptionUS Food and Drug Administration (CBER)
Suitable forPeople wanting a relatively small increase in breast size who have enough donor fat (ASPS)[1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons
SessionsMore than one session may be needed because part of the graft is resorbed[1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons
Imaging noteFat necrosis, cysts and calcifications can appear on mammograms and must be interpreted by a radiologist[1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons

概述

Breast fat grafting (fat transfer breast augmentation) is a surgical procedure that uses liposuction to take a patient's own fat, usually from the abdomen or flanks, and inject it into the breasts after processing. It is used for small cosmetic augmentations and alongside breast reconstruction. Only part of the injected fat survives. A 2024 meta-analysis of 25 studies found that about 54% of the grafted volume remained, with results varying by how the fat was prepared. Reported risks include fat necrosis, cysts, microcalcifications and infection. A meta-analysis of breast cancer patients found no difference in survival or local recurrence between those who had fat grafting and those who did not. In the US, fat removed and reinjected in the same operation can qualify for an FDA same-surgical-procedure exception. Readers should check the surgeon's training, how much volume to expect and what breast imaging follow-up is planned.

已验证服务机构

付费展示均有标注。验证与付费无关。
已验证

SC301의원

SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.

查看机构

证据与声明

官方声明是服务方的陈述,除非另有标注,否则未经 worldwiki 验证。
主张类型证据来源
Fat transfer breast augmentation produces a relatively small size increase and may need repeat sessions.outcome有限Fat Transfer Breast Augmentation

参考来源

独立来源比例 90% (18/20) · 提供方撰写 2
等级 A · 5等级 B · 10等级 C · 5
  1. 等级 C · organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
  2. 等级 C · organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
  3. 等级 C · organizationFat transfer for breast augmentation: The ins and outs of this implant alternativeAmerican Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
  4. 等级 B · journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract recordJournal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC) · 访问于 2026年9月20日 · 证据页
  5. 等级 B · journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract recordBMC Cancer (via Europe PMC) · 访问于 2026年9月20日 · 证据页
  6. 等级 B · journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central · 访问于 2026年9月20日 · 证据页
  7. 等级 A · governmentSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the ExceptionUS Food and Drug Administration (CBER) · 访问于 2026年9月19日 · 证据页
  8. 等级 A · governmentBreast enlargement (implants)NHS (UK National Health Service) · 访问于 2026年9月20日 · 证据页
  9. 等级 C · organizationBreast AugmentationAmerican Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
  10. 等级 B · academicAdvancing fat graft survival: from adipose-derived stem cell mechanisms to next-generation regenerative strategiesFrontiers in Cell and Developmental Biology (2026) · 访问于 2026年9月20日 · 证据页
  11. 等级 B · academic提供方撰写A Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction (Shin DJ, Ann Plast Surg 2023;90(4):380-384)Annals of Plastic Surgery · 访问于 2026年9月20日 · 证据页
  12. 等级 B · academicImpact of donor site on fat graft survival in autologous fat transfer to the breast: A systematic reviewJPRAS Open (2026) · 访问于 2026年9月20日 · 证据页
  13. 等级 B · academicCell-Assisted Lipotransfer: A Systematic Review of its EfficacyAesthetic Plastic Surgery (2024) · 访问于 2026年9月20日 · 证据页
  14. 等级 B · academicComparison of the Efficacy and Safety of Cell-Assisted Lipotransfer and Platelet-Rich Plasma Assisted LipotransferCell Transplantation (2021) · 访问于 2026年9月20日 · 证据页
  15. 等级 B · academicSafety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature reviewStem Cell Research & Therapy (2026) · 访问于 2026年9月20日 · 证据页
  16. 等级 B · academic提供方撰写Breast Augmentation by Fat Transplantation With Adipose-Derived Stem/Stromal Cells (Shin DJ, Aesthet Surg J Open Forum 2020)Aesthetic Surgery Journal Open Forum · 访问于 2026年9月20日 · 证据页
  17. 等级 A · governmentFDA Warns About Stem Cell TherapiesU.S. Food and Drug Administration · 访问于 2026年9月15日 · 证据页
  18. 等级 C · organization지방이식 (Fat transplantation) — N의학정보서울대학교병원 · 访问于 2026年9月19日 · 证据页
  19. 等级 A · governmentLiposuctionNHS (UK National Health Service) · 访问于 2026年9月20日 · 证据页
  20. 等级 A · governmentSurgical fat transfer (lipofilling)NHS (UK National Health Service) · 访问于 2026年9月20日 · 证据页
变更历史
首次发布 · 2026年9月14日